|
The Cochrane Collaboration
Cochrane Reviews |
| Explore | New + Updated | Other languages |
|
|
|
Anticonvulsants for preventing seizures in patients with chronic subdural haematomaRatilal BO, Costa J, Sampaio C SummaryAnti-epileptic drugs for preventing seizures in patients with long-term subdural haematomaChronic subdural haematoma (CSH) is a serious condition in which blood collects under the thickest membrane that surrounds the brain, known as the dura mater. CSH is usually caused by minor head injuries in which a vein has torn, and this happens in particular in older patients and patients with other brain problems. A CSH may cause seizures which can be dangerous. Some doctors give patients anti-epileptic drugs such as phenytoin or phenobarbital to try to prevent seizures. However, most patients with CSH will not have seizures and anti-epileptic drugs can have serious side effects. The review authors researched whether patients with a CSH who received anti-epileptic drugs had fewer seizures than those who did not. They searched the medical journal literature to find randomised controlled trials in which one group of patients received a treatment (anti-epileptic drugs, which could be given before or after surgery for the CSH) and was compared with a similar group which received a non-active or different treatment. The authors could find no randomised controlled trials. They did find other studies which were not as high quality evidence. These had conflicting results regarding the benefit of anti-epileptics. The review authors conclude that better research needs to be done on this topic and, for now, there is no clear evidence to support the regular use of anti-epileptic drugs for patients with long-term subdural haematoma.
This is a Cochrane review abstract and plain language summary, prepared and maintained by The Cochrane Collaboration, currently published in The Cochrane Database of Systematic Reviews 2009 Issue 4, Copyright © 2009 The Cochrane Collaboration. Published by John Wiley and Sons, Ltd.. The full text of the review is available in The Cochrane Library (ISSN 1464-780X).
This version first published online:
July 20. 2005 AbstractBackgroundAnticonvulsant therapy is sometimes used prophylactically in patients with chronic subdural haematoma, although the benefit is unclear. ObjectivesTo establish the effectiveness of prophylactic anticonvulsants in patients with chronic subdural haematoma, for both pre- and post-operative periods. Search strategyWe searched the Cochrane Injuries Group's Specialised Register, CENTRAL (The Cochrane Library, Issue 1, 2009), MEDLINE, EMBASE, LILACS, the American Association of Neurological Surgeons (AANS) Database and the conference proceedings of the European Association of Neurosurgical Societies (EANS). We also searched the reference lists of all relevant studies. Selection criteriaRandomised controlled trials comparing any anticonvulsant versus placebo or no intervention. Data collection and analysisNo trials met the inclusion criteria for the review. Main resultsNo randomised, controlled trials were identified. Authors' conclusionsNo formal recommendations can be made about the use of prophylactic anticonvulsants in patients with chronic subdural haematoma based on the literature currently available. Non-controlled studies came up with conflicting results. There is an urgent need for well-designed randomised controlled trials. |